About EO2Concepts
EO2Concepts is a company based in San Antonio (United States) founded in 2007. EO2Concepts has raised $31.11 million across 14 funding rounds from investors including A Plus Finance. EO2Concepts offers products and services including OxySpur Dressing, OxySpur Lite, and Oxygen Delivery Unit. EO2Concepts operates in a competitive market with competitors including Natrox, Advanced Oxygen Therapy, Vaporox, InotecAMD and Teknomar, among others.
- Total Equity Funding$31.11M (USD)
in 14 rounds
- Latest Funding Round$370K (USD), Series C
Nov 2022
- Investors
Products & Services of EO2Concepts
EO2Concepts offers a comprehensive portfolio of products and services, including OxySpur Dressing, OxySpur Lite, and Oxygen Delivery Unit.
Diffuses oxygen for healing medium to high exudating wounds effectively.
Provides oxygen diffusion for low exudating surgical wounds.
Portable generator that supplies humidified oxygen for wound therapy.
Apps and channels of EO2Concepts
its YouTube channel EO2 Concepts has 250 subscribers and 30 videos.
Videos from EO2Concepts
The most watched videos on EO2Concepts's YouTube channel, EO2 Concepts (250 subscribers). Click a video to play it here.
More on EO2 Concepts.
Funding Insights of EO2Concepts
EO2Concepts has successfully raised a total of $31.11M across 14 strategic funding rounds. The most recent funding activity was a Series C round of $370 thousand completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.11M
- Total Rounds 14
- Last Round Series C — $370,000
- First Round $732,500
(Jun 2009)
- Investors Count 1
Latest 10 of 14 funding rounds of EO2Concepts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $370,000 | Series C | – | – | – |
| Jan 2021 | $500,000 | Series C | – | – | – |
| Nov 2020 | $500,000 | Series C | – | – | – |
| Aug 2020 | $500,000 | Series C | – | – | – |
| Aug 2019 | – | Debt – Conventional | – | – | – |
| Aug 2019 | $2.3M | Series C | – | – | – |
| May 2018 | $8.71M | Series C | – | – | – |
| Jul 2017 | $907,500 | Series B | – | – | – |
| Apr 2014 | $70,000 | Series B | – | – | – |
| Jun 2012 | $4.29M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in EO2Concepts
EO2Concepts has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include A Plus Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A Plus Finance is engaged in investment management and financing services. | 1998 | aplusfinance.com | Paris, France |
Investor details for EO2Concepts
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EO2Concepts
13 people are tracked at EO2Concepts (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Cyndi Gilliam, BSN, RN, FACCWS | Director Clinical Affairs | Leadership |
Mark Q Niederauer | CEO & President | Leadership |
Bobby Nouri | Clinical Sales Director | Leadership |
Joe Moffett | President | Leadership |
David Kazynski | Sr. Vice President Sales and Marketing | Leadership |
Barb Dekur | Sales Manager | Team |
Dean Franchuk | Regional Account Manager | Team |
Jaudohn Hicks | Clinical Trials Manager, CCRC, CRA | Team |
Justin Cypert | Controller | Team |
Patti Burke-Martin | Country Manager | Team |
Scott Warantz | Business Development Manager | Team |
Patricia (Pat) Stanfel | Sales Manager Ontario North/East | Team |
Ryan Dowd | Territory Manager | Team |
Complete people profiles for EO2Concepts
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EO2Concepts
3 dated milestones of EO2Concepts across 15 years, from founding to its latest funding, stage changes and deals.
- Founded EO2Concepts is founded.
- Funding First funding round of $732K.
- Funding Latest funding round, Series C, of $370K.
Competitors of EO2Concepts
EO2Concepts operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natrox, Advanced Oxygen Therapy, Vaporox, InotecAMD and Teknomar, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natroxwoundcare.com | 2003 | Waterbeach, United Kingdom | $68.39M | 31 | Oxygen-based wound therapy devices are developed for healing non-healing wounds. | |
| aotinc.net | 2004 | Oceanside, United States | – | – | Solutions for treating severe acute and chronic wounds are developed. | |
| vaporox.com | 2016 | Denver, United States | $2.25M | – | Developer of medical device for the wound treatment | |
| inotecamd.com | 2003 | Cambridge, United Kingdom | – | 14 | Chronic wound solutions are developed via portable oxygen-enrichment devices. | |
| teknomar.eu | 1993 | Ankara, Turkey | – | – | Produces sterilization devices, air sterilizers, and wound care equipment for medical use. | |
| numobag.com | 2006 | Northridge, United States | $950,000 | – | Topical hyperbaric oxygen therapy for wound healing is developed. | |
| oz-recovery.com | 1995 | Ramat Gan, Israel | – | – | Provides a medical device designed for chronic wound healing. |
Detailed competitors of EO2Concepts
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EO2Concepts
The website of EO2Concepts (eo2.com) receives about 4.5K visits a month.
- Monthly visits4.5K
▲ 31.3% vs previous month
Websites whose visitors overlap most with EO2Concepts. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| emedicinehealth.com | 100% | – | #83,156 | View details | |
footprintmed.com | footprintmed.com | 61% | – | – | – |
| scorpiusbiologics.com | 54% | 3.6K | #5,029,935 | View details |
Latest news on Eo2concepts
Complete news archive for EO2Concepts
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to EO2Concepts
10 companies that operate in the same segment as EO2Concepts (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EO2Concepts
EO2Concepts was founded in 2007 and raised its 1st funding round 2 years after it was founded.
EO2Concepts is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
EO2Concepts is a funded company, having raised a total of $31.11M across 14 funding rounds to date. The company's 1st funding round was a Series B of $4.29M, raised on Jun 2009.
EO2Concepts develops and commercializes electrochemical low-dose tissue oxygenation and wound monitoring systems for the treatment of chronic wounds to promote tissue viability. The device, TransCu O2, is a portable oxygen concentrator for wound care that feeds a continuous stream of pure oxygen directly to the wound 247 to aid in the wound healing process. It utilizes enhanced fuel cell technology to electrochemically generate pure oxygen. FDA cleared Class II medical device.
EO2Concepts's top competitors include Natrox, Vaporox and Advanced Oxygen Therapy.
EO2Concepts offers OxySpur Dressing, OxySpur Lite, and Oxygen Delivery Unit.
EO2Concepts has 1 investor. Key investors include A Plus Finance.
EO2Concepts operates through Electrochemical Oxygen Concepts, Inc..